Literature DB >> 10856240

The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death.

M Kurokawa1, K Mitani, T Yamagata, T Takahashi, K Izutsu, S Ogawa, T Moriguchi, E Nishida, Y Yazaki, H Hirai.   

Abstract

Evi-1 encodes a nuclear protein involved in leukemic transformation of hematopoietic cells. Evi-1 possesses two sets of zinc finger motifs separated into two domains, and its characteristics as a transcriptional regulator have been described. Here we show that Evi-1 acts as an inhibitor of c-Jun N-terminal kinase (JNK), a class of mitogen-activated protein kinases implicated in stress responses of cells. Evi-1 physically interacts with JNK, although it does not affect its phosphorylation. This interaction is required for inhibition of JNK. Evi-1 protects cells from stress-induced cell death with dependence on the ability to inhibit JNK. These results reveal a novel function of Evi-1, which provides evidence for inhibition of JNK by a nuclear oncogene product. Evi-1 blocks cell death by selectively inhibiting JNK, thereby contributing to oncogenic transformation of cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10856240      PMCID: PMC203342          DOI: 10.1093/emboj/19.12.2958

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  56 in total

1.  The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development.

Authors:  P R Hoyt; C Bartholomew; A J Davis; K Yutzey; L W Gamer; S S Potter; J N Ihle; M L Mucenski
Journal:  Mech Dev       Date:  1997-07       Impact factor: 1.882

2.  MKK7 is a stress-activated mitogen-activated protein kinase kinase functionally related to hemipterous.

Authors:  P M Holland; M Suzanne; J S Campbell; S Noselli; J A Cooper
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

4.  Activation of EVI1 gene expression in human acute myelogenous leukemias by translocations spanning 300-400 kilobases on chromosome band 3q26.

Authors:  K Morishita; E Parganas; C L William; M H Whittaker; H Drabkin; J Oval; R Taetle; M B Valentine; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

5.  The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression.

Authors:  M Faris; N Kokot; K Latinis; S Kasibhatla; D R Green; G A Koretzky; A Nel
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

Review 6.  Mitogen-activated protein kinase pathways.

Authors:  M J Robinson; M H Cobb
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

7.  Loss of erythropoietin responsiveness in erythroid progenitors due to expression of the Evi-1 myeloid-transforming gene.

Authors:  B L Kreider; S H Orkin; J N Ihle
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

Review 8.  The mitogen-activated protein kinase signal transduction pathway.

Authors:  R J Davis
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

9.  A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses.

Authors:  T Moriguchi; F Toyoshima; N Masuyama; H Hanafusa; Y Gotoh; E Nishida
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

10.  The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3.

Authors:  M Kurokawa; K Mitani; K Irie; T Matsuyama; T Takahashi; S Chiba; Y Yazaki; K Matsumoto; H Hirai
Journal:  Nature       Date:  1998-07-02       Impact factor: 49.962

View more
  31 in total

1.  Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression.

Authors:  Jiping Chen; Mark F Stinski
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

Review 2.  Evi-1 as a critical regulator of leukemic cells.

Authors:  Susumu Goyama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2010-06-08       Impact factor: 2.490

3.  Leukemia-related transcription factor TEL is negatively regulated through extracellular signal-regulated kinase-induced phosphorylation.

Authors:  Kazuhiro Maki; Honoka Arai; Kazuo Waga; Ko Sasaki; Fumihiko Nakamura; Yoichi Imai; Mineo Kurokawa; Hisamaru Hirai; Kinuko Mitani
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Overexpression of EVI1 interferes with cytokinesis and leads to accumulation of cells with supernumerary centrosomes in G0/1 phase.

Authors:  Kadin Karakaya; Friederike Herbst; Claudia Ball; Hanno Glimm; Alwin Krämer; Harald Löffler
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

5.  EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.

Authors:  Emilie A Bard-Chapeau; Jayantha Gunaratne; Pankaj Kumar; Belinda Q Chua; Julius Muller; Frederic A Bard; Walter Blackstock; Neal G Copeland; Nancy A Jenkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-15       Impact factor: 11.205

6.  Point mutations in two EVI1 Zn fingers abolish EVI1-GATA1 interaction and allow erythroid differentiation of murine bone marrow cells.

Authors:  Leopoldo Laricchia-Robbio; Raffaella Fazzina; Donglan Li; Ciro R Rinaldi; Kisaly K Sinha; Soumen Chakraborty; Giuseppina Nucifora
Journal:  Mol Cell Biol       Date:  2006-09-05       Impact factor: 4.272

7.  A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci.

Authors:  Jin-Xin Bei; Yi Li; Wei-Hua Jia; Bing-Jian Feng; Gangqiao Zhou; Li-Zhen Chen; Qi-Sheng Feng; Hui-Qi Low; Hongxing Zhang; Fuchu He; E Shyong Tai; Tiebang Kang; Edison T Liu; Jianjun Liu; Yi-Xin Zeng
Journal:  Nat Genet       Date:  2010-05-30       Impact factor: 38.330

8.  Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability.

Authors:  Eun Ji Choi; Min Sung Kim; Sang Yong Song; Nam Jin Yoo; Sug Hyung Lee
Journal:  Pathol Oncol Res       Date:  2016-09-13       Impact factor: 3.201

Review 9.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

10.  Inducible expression of EVI1 in human myeloid cells causes phenotypes consistent with its role in myelodysplastic syndromes.

Authors:  Torsten A Konrad; Anna Karger; Hubert Hackl; Ilse Schwarzinger; Irene Herbacek; Rotraud Wieser
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.